Red Light Therapy Wavelengths Explained (2026)

If you've ever shopped for a red light therapy device, you've seen the wavelength numbers: 630nm, 660nm, 850nm, 940nm. Some devices list one wavelength, some list two, and some advertise five or more. Marketing materials throw these numbers around like they're self-explanatory, but for most people, they're not. What do these numbers actually mean? Does it matter whether your device uses 630nm or 660nm? Why do some devices include near-infrared wavelengths you can't even see?

These are important questions because wavelength selection is the single most important spec on any red light therapy device. Get the wavelengths right, and you have a clinically relevant tool. Get them wrong, and you have an expensive nightlight. This guide breaks down every wavelength you'll encounter, explains what the research says about each one, and gives you the knowledge to evaluate any device's claims with confidence.

What Is a Wavelength? The Basics

Light travels in waves, and wavelength is the distance between consecutive peaks of those waves. It's measured in nanometers (nm), where one nanometer is one billionth of a meter. The wavelength of light determines its color (in the visible spectrum) and its biological effects.

The electromagnetic spectrum spans from gamma rays (extremely short wavelengths) to radio waves (extremely long wavelengths). The visible light spectrum, what your eyes can see, falls between roughly 380nm (violet) and 700nm (deep red). Beyond 700nm, you enter the near-infrared range, which is invisible to the human eye but still biologically active.

Red light therapy uses wavelengths in two key ranges: visible red light (roughly 620nm to 700nm) and near-infrared light (roughly 700nm to 1000nm). Within these ranges, specific wavelengths have been studied more extensively than others, and not all wavelengths within these ranges are equally effective.

The Visible Red Spectrum: 620nm to 700nm

Visible red light is the portion of the red light therapy spectrum that you can actually see. When you turn on a red light therapy device, the red glow you observe comes from LEDs in this range. Several specific wavelengths within this band have been studied clinically.

620nm to 630nm: The Early Research Wavelength

Some of the earliest photobiomodulation research used wavelengths in the 620nm to 630nm range. These wavelengths are effective at stimulating surface-level cellular responses, and they have documented benefits for wound healing and superficial skin conditions. You'll find 630nm LEDs in some older or budget devices.

However, 630nm light has a shallower penetration depth than 660nm. It's absorbed more readily by the outer layers of skin, which means less energy reaches the deeper dermal layers and underlying tissues. For purely surface-level applications like minor wound healing or very superficial skin treatments, 630nm can work. But for anything requiring deeper penetration, even within the skin itself, 660nm is the superior choice.

660nm: The Gold Standard for Red Light

If there's one wavelength that dominates the clinical literature on red light therapy, it's 660nm. This wavelength sits in the sweet spot of the absorption spectrum for cytochrome c oxidase, the key enzyme in the mitochondrial electron transport chain that's responsible for the biological effects of red light therapy.

At 660nm, light penetrates approximately 8 to 10 millimeters into tissue. That's deep enough to reach the dermis (the deeper layer of skin where collagen is produced), superficial blood vessels, lymphatic vessels, hair follicles, and shallow nerve endings. The research on 660nm is extensive:

• Collagen production: Multiple studies show 660nm light stimulates fibroblast activity and increases collagen synthesis, making it the primary wavelength for anti-aging and skin rejuvenation applications.
• Wound healing: Clinical trials demonstrate accelerated wound closure, reduced inflammation at wound sites, and improved tissue remodeling with 660nm treatment.
• Acne reduction: Research shows 660nm light reduces inflammatory acne lesions by decreasing inflammation and supporting skin repair processes.
• Hair growth: Studies on androgenetic alopecia (pattern hair loss) have shown increased hair density and thickness with 660nm treatment, likely through improved blood flow to hair follicles and stimulation of follicular stem cells.
• Surface inflammation: Joint inflammation close to the skin surface, tendinitis, and superficial tissue inflammation all respond well to 660nm.

The 660nm wavelength is so well supported that any serious red light therapy device should include it. If a device only offers one red wavelength, 660nm is the one you want.

See the Novaa Glow Mask (660nm for Skin Health)

670nm: The Emerging Contender

Recent research has drawn attention to 670nm as another potentially valuable wavelength. Some studies, particularly in the field of retinal health and mitochondrial function, have used 670nm with positive results. The penetration depth is similar to 660nm, and the biological mechanism is the same (cytochrome c oxidase absorption).

At this point, 670nm doesn't have nearly the volume of research that 660nm does. It may prove to be equally effective for certain applications, but until the evidence base grows, 660nm remains the better-supported choice. Some premium devices now include both 660nm and 670nm LEDs, which is fine, but 670nm alone would not be as well validated as 660nm alone.

680nm to 700nm: The Edge of Visibility

As you approach 700nm, you're getting close to the boundary between visible red light and near-infrared. Light at these wavelengths begins to penetrate slightly deeper than 660nm but has a weaker absorption by cytochrome c oxidase. The clinical evidence for wavelengths in this range is thinner. Some combination devices include LEDs in this range as part of a multi-wavelength approach, but they're not the primary therapeutic wavelengths. Think of them as supplementary rather than foundational.

The Near-Infrared Spectrum: 700nm to 1000nm

Near-infrared (NIR) light is invisible to the human eye. When you use a device with NIR LEDs, you won't see any light coming from them (though some devices include a faint red indicator LED so you know they're on). Despite being invisible, NIR wavelengths are biologically powerful because they penetrate much deeper into tissue than visible red light.

810nm: The Neurological Research Wavelength

810nm has attracted significant attention in neurological research. Studies on traumatic brain injury (TBI), stroke recovery, and cognitive function have frequently used 810nm light applied transcranially (through the skull). This wavelength appears to penetrate bone tissue reasonably well, which is why it's the wavelength of choice for brain-related applications.

Research on 810nm for brain health is still in relatively early stages, but the results from initial clinical trials and animal studies are promising. It's worth noting that brain applications require specific devices designed for transcranial delivery, which is a different use case than general body treatment.

830nm: The Tissue Repair Wavelength

830nm is another wavelength with a notable research base, particularly for wound healing, tissue repair, and nerve regeneration. Some studies have found 830nm to be effective for deeper wound healing applications and post-surgical recovery. It penetrates deeper than visible red wavelengths but not quite as deep as 850nm.

In practice, 830nm and 850nm are close enough in the spectrum that their effects overlap significantly. Most device manufacturers have standardized on 850nm because it has a broader research base, but devices using 830nm are not at a disadvantage for most applications.

850nm: The Gold Standard for Near-Infrared

Just as 660nm dominates the visible red research, 850nm dominates the near-infrared research. This wavelength penetrates 30 to 40 millimeters or more into tissue, reaching muscles, joints, tendons, bones, and deep connective tissue. The depth of penetration is what makes 850nm essential for anything beyond surface-level skin treatment.

The clinical evidence for 850nm is extensive:

• Deep tissue pain relief: Studies show significant pain reduction in conditions affecting muscles, joints, and connective tissue. The depth of penetration allows the light to reach the tissues where inflammation and damage are occurring.
• Joint arthritis: Research on knee, hip, and hand osteoarthritis consistently uses near-infrared wavelengths around 850nm because the joint capsule and cartilage require deep penetration to reach.
• Muscle recovery: Athletic recovery studies demonstrate reduced delayed onset muscle soreness (DOMS), faster strength recovery, and decreased inflammatory markers in muscles treated with 850nm.
• Bone healing: Animal studies and preliminary human research suggest 850nm light can support fracture healing by stimulating osteoblast activity (the cells that build bone).
• Tendon and ligament repair: Research shows accelerated healing of tendon injuries, which sit deep beneath the skin and require NIR penetration to reach effectively.
• Nerve function: Studies on peripheral neuropathy and nerve injuries have shown improvements with 850nm treatment, including reduced numbness and improved nerve conduction.

For any application involving tissue deeper than 10 millimeters below the skin surface, 850nm is the wavelength you need. This is why serious red light therapy devices pair 660nm with 850nm: together, they cover both surface and deep tissue applications.

See the Novaa Light Pad (660nm + 850nm Dual Wavelength)

940nm: The Deep Penetration Wavelength

940nm sits further into the near-infrared range and offers even deeper tissue penetration than 850nm. Some research has explored this wavelength for fat reduction, deep tissue heating, and circulation enhancement. However, 940nm falls in a region of the absorption spectrum where water absorption increases, meaning more of the light energy is absorbed by water in the tissue before reaching the target cells.

This water absorption issue is why 940nm hasn't become a primary therapeutic wavelength despite its deeper penetration. Some devices include 940nm LEDs as part of a multi-wavelength array, which may provide additional benefits, but 940nm alone is not as clinically supported as 850nm for most applications.

980nm and Beyond

Wavelengths above 950nm see rapidly increasing water absorption, which limits their therapeutic utility. While some devices market wavelengths in this range, the clinical evidence is sparse. The energy is increasingly absorbed by water in the tissue rather than by the chromophores (like cytochrome c oxidase) that produce the therapeutic effects. Most researchers and clinicians consider the effective therapeutic window to close around 950nm.

Why 660nm + 850nm Is the Gold Standard Combination

Now that you understand the individual wavelengths, the reason 660nm and 850nm are paired in quality devices becomes clear. These two wavelengths represent the peak absorption points for cytochrome c oxidase in their respective ranges (visible red and near-infrared), and they complement each other perfectly in terms of penetration depth.

• 660nm handles the first 8 to 10mm: skin, dermis, surface blood vessels, lymphatic vessels, and shallow tissue.
• 850nm handles everything deeper: muscles, joints, tendons, ligaments, bones, and deep connective tissue.

Together, they provide therapeutic coverage from the skin surface down to 30 to 40mm or more. There's no gap in coverage, no depth that goes untreated. This is why the majority of clinical studies showing positive outcomes for pain, recovery, skin health, and inflammation use wavelengths at or near these two values.

When you see a device advertising 660nm + 850nm, it's not a marketing choice. It's a reflection of where the strongest clinical evidence points. Devices that use significantly different wavelengths (say, 630nm + 940nm) are not working with the optimal absorption peaks and may deliver less effective treatment as a result.

See the Deep Healing Pad XL (Medical-Grade 660nm + 850nm)

Penetration Depth: What Actually Reaches Your Tissue

Understanding penetration depth is critical for choosing the right wavelength for your needs. Here's a practical breakdown of how deep different wavelengths reach and what tissues they affect at those depths.

Surface Level (0 to 3mm): Epidermis and Upper Dermis

All therapeutic wavelengths from 620nm to 850nm deliver energy at this level. For conditions limited to the skin surface (minor wounds, superficial redness, surface acne), almost any red light wavelength will work. This is why even budget devices with imprecise wavelengths can show some results for basic skin applications.

Mid Depth (3 to 10mm): Lower Dermis, Collagen Layer, Superficial Vessels

This is where 660nm excels. It delivers strong energy to the collagen-producing layer of the skin, which is why it's the gold standard for anti-aging, scar treatment, and skin rejuvenation. Hair follicles also sit at this depth, making 660nm the primary wavelength for hair growth stimulation. Wavelengths shorter than 650nm deliver significantly less energy at this depth.

Deep Tissue (10 to 40mm+): Muscles, Joints, Tendons, Bone

Only near-infrared wavelengths (primarily 850nm) deliver meaningful energy at these depths. If you're treating knee arthritis, muscle soreness, a deep tendon injury, or hip joint inflammation, 850nm is essential. Visible red light at 660nm simply doesn't penetrate far enough to reach these structures with clinically relevant energy levels. This is the most important consideration for anyone dealing with musculoskeletal conditions.

How to Evaluate Device Wavelength Claims

The market has its share of misleading products. Here's what to look for and what to be wary of when evaluating a device's wavelength specifications.

Green Flags

• Exact wavelengths listed. A reputable device lists its wavelengths precisely: "660nm + 850nm" or "630nm + 660nm + 850nm." If the manufacturer knows what's in their device, they'll tell you the exact numbers.
• Third-party testing data. The best manufacturers provide independent spectral analysis showing the actual output wavelengths of their LEDs. This confirms the stated wavelengths are accurate.
• Irradiance specifications. Along with wavelength, the power density (measured in mW/cm2) at the treatment surface matters. A device with the right wavelengths but insufficient power won't deliver enough energy to produce clinical effects.
• FDA clearance. FDA Class II medical device clearance requires documentation of the device's output specifications, adding a layer of verification to the manufacturer's claims.

Red Flags

• Vague wavelength descriptions. Phrases like "red light" or "infrared" without specific nanometer values should make you cautious. Legitimate devices specify exact wavelengths.
• "Full spectrum" claims without specifics. Some devices claim to deliver a "full spectrum" of therapeutic wavelengths. This sounds impressive but often means the device uses broad-spectrum LEDs that waste energy on non-therapeutic wavelengths while delivering insufficient energy at the wavelengths that actually matter.
• Unusually many wavelengths. A device advertising 7 or 8 different wavelengths may sound advanced, but more wavelengths means fewer LEDs at each wavelength. If a device has 60 LEDs split across 6 wavelengths, that's only 10 LEDs per wavelength. You'd get more therapeutic benefit from 60 LEDs split between just 660nm and 850nm (30 each).
• No power specifications. If a device lists wavelengths but provides no information about power output, irradiance, or energy density, you have no way to know if it delivers clinically relevant doses. Low-power devices with correct wavelengths still underperform.
• Extremely low prices. Quality LEDs with precisely controlled wavelengths and sufficient power output cost money to manufacture. If a device is dramatically cheaper than established competitors, the LEDs are likely lower quality, with less precise wavelengths and lower power output.

Wavelength Recommendations by Condition

Here's a practical reference for which wavelengths are most important for common applications.

Skin Health and Anti-Aging

Primary wavelength: 660nm. The collagen layer and skin structures are within the penetration range of visible red light. 850nm adds anti-inflammatory benefits but isn't strictly necessary for purely cosmetic applications. A dual-wavelength device still gives better overall results.

Check Novaa Glow Therapy Mask for Skin

Joint Pain and Arthritis

Primary wavelength: 850nm. Joints sit beneath skin, fascia, and sometimes muscle. Near-infrared penetration is essential. 660nm provides supplementary anti-inflammatory effects in the tissues surrounding the joint. A dual-wavelength device is strongly recommended.

Muscle Recovery and Athletic Performance

Primary wavelength: 850nm. Large muscle groups require deep penetration to treat effectively. 660nm contributes to surface tissue recovery and blood flow enhancement. Dual-wavelength devices provide the most comprehensive recovery treatment.

Check Novaa Recovery Pod for Full Body Recovery

Wound Healing

Primary wavelength: 660nm. Surface wounds and surgical incisions respond well to red light, which stimulates fibroblast activity and collagen deposition. 850nm can support deeper healing in larger wounds. Both wavelengths together accelerate the overall healing cascade.

Pain Management (General)

Both wavelengths equally important. 660nm addresses surface inflammation and skin-level pain receptors. 850nm reaches deeper pain generators in muscles, joints, and connective tissue. A dual-wavelength device is the minimum recommendation for effective pain management.

Check Novaa Light Pad for Pain Management

Frequently Asked Questions

Is 630nm significantly worse than 660nm for red light therapy?

Not dramatically worse, but measurably less effective for most applications. 630nm has a shallower penetration depth and slightly lower cytochrome c oxidase absorption compared to 660nm. For very superficial applications, the difference may be minimal. For anything requiring penetration into the dermis or deeper, 660nm delivers more energy to the target tissue. Given the choice, 660nm is the better option, which is why it has become the industry standard for the visible red wavelength in clinical-grade devices.

Can I get the same benefits from a single-wavelength device?

A single-wavelength device will be effective for conditions within that wavelength's penetration range. A 660nm-only device works well for skin health, superficial wound healing, and surface inflammation. An 850nm-only device works well for deep tissue pain, joint issues, and muscle recovery. However, you'll miss the benefits of the other wavelength range. A dual-wavelength device gives you the full spectrum of therapeutic coverage from surface to deep tissue, which is why researchers and clinicians consistently recommend them.

Do more wavelengths in a device mean better results?

Not necessarily. The key research supports 660nm and 850nm as the two most clinically validated wavelengths. Adding additional wavelengths (like 630nm, 810nm, or 940nm) may provide marginal supplementary benefits, but each additional wavelength means fewer LEDs dedicated to the primary therapeutic wavelengths. A device with 60 LEDs split evenly between 660nm and 850nm will generally outperform a device with the same 60 LEDs split across 5 different wavelengths. Focus on quality at the two gold standard wavelengths rather than quantity of wavelengths.

How do I know if a device's wavelength claims are accurate?

Look for FDA Class II medical device clearance, which requires the manufacturer to document and verify their device's output specifications. Check for third-party spectral analysis or independent lab testing data. Reputable manufacturers like NovaaLab publish their specifications openly because they can back them up. If a manufacturer is vague about their specs or doesn't provide independent verification, treat their claims with skepticism. You can also look for user reviews from people who have tested devices with spectrometers, which has become increasingly common in the red light therapy community.

Does wavelength matter more than power output?

Both matter, and they work together. The correct wavelength ensures the light is absorbed by the right biological targets (cytochrome c oxidase). Sufficient power output ensures enough photons reach the target tissue to produce a meaningful biological response. A device with perfect wavelengths but extremely low power won't deliver enough energy. A device with high power but wrong wavelengths will deliver lots of energy that doesn't trigger the right cellular response. You need both: correct wavelengths (660nm + 850nm) and adequate power (look for at least 100mW per LED or irradiance above 50mW/cm2 at the treatment surface).

Final Thoughts

Understanding wavelengths transforms you from a passive consumer into an informed buyer. The core takeaway is straightforward: 660nm and 850nm are the two most clinically supported wavelengths in red light therapy. They cover surface and deep tissue applications respectively, and together they provide comprehensive therapeutic coverage for virtually every condition red light therapy has been studied for.

When evaluating devices, prioritize precise wavelength specifications (660nm + 850nm), adequate power output (120mW+ per LED), and verifiable quality indicators like FDA Class II clearance. Be skeptical of devices with vague specs, unusually many wavelengths, or no power specifications. The devices that produce real clinical results are the ones built around the science, and the science clearly points to 660nm and 850nm as the gold standard combination.

NovaaLab's entire device lineup uses this research-backed dual wavelength approach. Every device delivers both 660nm red and 850nm near-infrared light at medical-grade power output, with FDA Class II clearance to verify the claims. Combined with a 60-day money-back guarantee, it's a straightforward choice for anyone who wants clinically validated wavelengths in a well-built device.

Browse NovaaLab Dual-Wavelength Devices